Investor Relations





         Nasdaq: PRPH

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2020

Company Overview

ProPhase Labs (NASDAQ: PRPH) (“ProPhase”) is a diversified biotech and genomics company that seeks to leverage its CLIA lab services to provide whole genome sequencing and research direct to consumers and also build a genomics data base to be used for further research including clinical studies.

Investor Contact Information

Company

ProPhase Labs, Inc.
711 Stewart Ave
Suite 200
Garden City, NY 11530

Investor Relations

CORE IR
T: (516) 222-2560
InvestorRelations@ProPhaseLabs.com